FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892026456> ?p ?o ?g. }

• W2892026456 endingPage "2765" @default.
• W2892026456 startingPage "2751" @default.
• W2892026456 abstract "Increasing evidence indicates that tumor-initiating cells (TICs) are responsible for the occurrence, development, recurrence, and development of the drug resistance of cancer. MicroRNA (miRNA) plays a significant functional role by directly regulating targets of TIC-triggered non-small-cell lung cancer (NSCLC), but little is known about the function of the miR-30 family in TICs. In this study, we found the miR-30 family to be downregulated during the spheroid formation of NSCLC cells, and patients with lower miR-30a/c expression had shorter overall survival (OS) and progression-free survival (PFS). Moreover, transmembrane 4 super family member 1 (TM4SF1) was confirmed to be a direct target of miR-30a/c. Concomitant low expression of miR-30a/c and high expression of TM4SF1 correlated with a shorter median OS and PFS in NSCLC patients. miR-30a/c significantly inhibited stem-like characteristics in vitro and in vivo via suppression of its target gene TM4SF1, and then it inhibited the activity of the mTOR/AKT-signaling pathway. Thus, our data provide the first evidence that TM4SF1 is a direct target of miR-30a/c and miR-30a/c inhibits the stemness and proliferation of NSCLC cells by targeting TM4SF1, suggesting that miR-30a/c and TM4SF1 may be useful as tumor biomarkers for the diagnosis and treatment of NSCLC patients. Increasing evidence indicates that tumor-initiating cells (TICs) are responsible for the occurrence, development, recurrence, and development of the drug resistance of cancer. MicroRNA (miRNA) plays a significant functional role by directly regulating targets of TIC-triggered non-small-cell lung cancer (NSCLC), but little is known about the function of the miR-30 family in TICs. In this study, we found the miR-30 family to be downregulated during the spheroid formation of NSCLC cells, and patients with lower miR-30a/c expression had shorter overall survival (OS) and progression-free survival (PFS). Moreover, transmembrane 4 super family member 1 (TM4SF1) was confirmed to be a direct target of miR-30a/c. Concomitant low expression of miR-30a/c and high expression of TM4SF1 correlated with a shorter median OS and PFS in NSCLC patients. miR-30a/c significantly inhibited stem-like characteristics in vitro and in vivo via suppression of its target gene TM4SF1, and then it inhibited the activity of the mTOR/AKT-signaling pathway. Thus, our data provide the first evidence that TM4SF1 is a direct target of miR-30a/c and miR-30a/c inhibits the stemness and proliferation of NSCLC cells by targeting TM4SF1, suggesting that miR-30a/c and TM4SF1 may be useful as tumor biomarkers for the diagnosis and treatment of NSCLC patients." @default.
• W2892026456 created "2018-09-27" @default.
• W2892026456 creator A5000029097 @default.
• W2892026456 creator A5000898936 @default.
• W2892026456 creator A5002454695 @default.
• W2892026456 creator A5012288680 @default.
• W2892026456 creator A5014828679 @default.
• W2892026456 creator A5021104669 @default.
• W2892026456 creator A5027972086 @default.
• W2892026456 creator A5034048160 @default.
• W2892026456 creator A5043443793 @default.
• W2892026456 creator A5047086634 @default.
• W2892026456 creator A5047579560 @default.
• W2892026456 creator A5051184009 @default.
• W2892026456 creator A5060808786 @default.
• W2892026456 creator A5063265167 @default.
• W2892026456 creator A5063758072 @default.
• W2892026456 creator A5065069403 @default.
• W2892026456 creator A5065737143 @default.
• W2892026456 creator A5077092010 @default.
• W2892026456 creator A5090391111 @default.
• W2892026456 date "2018-12-01" @default.
• W2892026456 modified "2023-10-14" @default.
• W2892026456 title "miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1" @default.
• W2892026456 cites W1829044527 @default.
• W2892026456 cites W1973768397 @default.
• W2892026456 cites W1977683152 @default.
• W2892026456 cites W1978212773 @default.
• W2892026456 cites W1981376185 @default.
• W2892026456 cites W1983266682 @default.
• W2892026456 cites W1985345335 @default.
• W2892026456 cites W1993793897 @default.
• W2892026456 cites W1998605742 @default.
• W2892026456 cites W2005335686 @default.
• W2892026456 cites W2036090950 @default.
• W2892026456 cites W2037207845 @default.
• W2892026456 cites W2050879491 @default.
• W2892026456 cites W2055234935 @default.
• W2892026456 cites W2062865554 @default.
• W2892026456 cites W2077046830 @default.
• W2892026456 cites W2086424362 @default.
• W2892026456 cites W2093238681 @default.
• W2892026456 cites W2096334202 @default.
• W2892026456 cites W2104517740 @default.
• W2892026456 cites W2144832461 @default.
• W2892026456 cites W2165983921 @default.
• W2892026456 cites W2190463667 @default.
• W2892026456 cites W2293916969 @default.
• W2892026456 cites W2306179365 @default.
• W2892026456 cites W2339789193 @default.
• W2892026456 cites W2419606856 @default.
• W2892026456 cites W2475748042 @default.
• W2892026456 cites W2478670465 @default.
• W2892026456 cites W2538373463 @default.
• W2892026456 cites W2560443862 @default.
• W2892026456 cites W2560936010 @default.
• W2892026456 cites W2583949540 @default.
• W2892026456 cites W2585760107 @default.
• W2892026456 cites W2613006951 @default.
• W2892026456 cites W2615763728 @default.
• W2892026456 cites W2615770054 @default.
• W2892026456 cites W2663238968 @default.
• W2892026456 cites W2734560442 @default.
• W2892026456 cites W2739420952 @default.
• W2892026456 cites W2765451139 @default.
• W2892026456 cites W2768475613 @default.
• W2892026456 cites W2781018804 @default.
• W2892026456 cites W2784121544 @default.
• W2892026456 cites W2789376122 @default.
• W2892026456 cites W2794851756 @default.
• W2892026456 cites W2802353887 @default.
• W2892026456 cites W2888823314 @default.
• W2892026456 doi "https://doi.org/10.1016/j.ymthe.2018.09.006" @default.
• W2892026456 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6277537" @default.
• W2892026456 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30301667" @default.
• W2892026456 hasPublicationYear "2018" @default.
• W2892026456 type Work @default.
• W2892026456 sameAs 2892026456 @default.
• W2892026456 citedByCount "27" @default.
• W2892026456 countsByYear W28920264562019 @default.
• W2892026456 countsByYear W28920264562020 @default.
• W2892026456 countsByYear W28920264562021 @default.
• W2892026456 countsByYear W28920264562022 @default.
• W2892026456 countsByYear W28920264562023 @default.
• W2892026456 crossrefType "journal-article" @default.
• W2892026456 hasAuthorship W2892026456A5000029097 @default.
• W2892026456 hasAuthorship W2892026456A5000898936 @default.
• W2892026456 hasAuthorship W2892026456A5002454695 @default.
• W2892026456 hasAuthorship W2892026456A5012288680 @default.
• W2892026456 hasAuthorship W2892026456A5014828679 @default.
• W2892026456 hasAuthorship W2892026456A5021104669 @default.
• W2892026456 hasAuthorship W2892026456A5027972086 @default.
• W2892026456 hasAuthorship W2892026456A5034048160 @default.
• W2892026456 hasAuthorship W2892026456A5043443793 @default.
• W2892026456 hasAuthorship W2892026456A5047086634 @default.
• W2892026456 hasAuthorship W2892026456A5047579560 @default.
• W2892026456 hasAuthorship W2892026456A5051184009 @default.
• W2892026456 hasAuthorship W2892026456A5060808786 @default.

• next